Huma is a Healthtech company based in London, United Kingdom. It has raised $360M in total funding. Latest round: Series D.
Huma funding overview
Huma is a Healthtech company based in London, United Kingdom. Huma has raised $360M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in July 2024. The round record for Huma runs through 2024; nothing later has been disclosed. Investors on record include Leaps by Bayer, Hitachi Ventures, AstraZeneca, Samsung Next, Sony Innovation Fund, HATGR and 1 others. 7 distinct backers are named across the disclosed rounds.
Huma at a glance
Total raised
$360M
Latest round
Series D
Latest round date
July 2024
Industry
Healthtech
Headquarters
London, United Kingdom
Notable investors
Leaps by Bayer, Hitachi Ventures, AstraZeneca, Samsung Next, Sony Innovation Fund, HATGR, Hat Fund
Frequently asked about Huma funding
How much has Huma raised?
Huma has raised $360M in total disclosed funding across the rounds on record.
Who has invested in Huma?
Leaps by Bayer, Hitachi Ventures, AstraZeneca, Samsung Next, Sony Innovation Fund, HATGR are named among the investors backing Huma.
What was the latest Huma funding round?
The most recent disclosed round is a Series D, announced in July 2024.
Where is Huma based?
Huma is based in London, United Kingdom.
What sector does Huma operate in?
Huma is tracked under Healthtech from London, United Kingdom, with $360M in disclosed funding.
When did Huma last raise?
The last disclosed Huma round closed in July 2024 at Series D.
We update the Huma record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Healthtech companies in London and their backers are listed below.
